Selected research
Market Structure
Global Umifenovir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Umifenovir market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Umifenovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Umifenovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Umifenovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Umifenovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Umifenovir include Yichang Tianren Pharmaceutical Co.,Ltd, Shenyang Coupling Biomedical Technology Co., Ltd., Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD and JSC Pharmstandard, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Umifenovir market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Umifenovir and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Umifenovir sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Umifenovir market size, projected growth trends, production technologies, key applications, and end-use industries.
Umifenovir Segment by Company
Yichang Tianren Pharmaceutical Co.,Ltd
Shenyang Coupling Biomedical Technology Co., Ltd.
Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD
JSC Pharmstandard
Umifenovir Segment by Type
Tablet
Capsule
Others
Umifenovir Segment by Application
Drug Store
Hospital
Clinics
Others
Umifenovir Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Umifenovir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Umifenovir and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Umifenovir.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Umifenovir market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Umifenovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Umifenovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Umifenovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
- Others
Applications
- Drug Store
- Hospital
- Clinics
- Others
Companies covered
- Yichang Tianren Pharmaceutical Co.,Ltd
- Shenyang Coupling Biomedical Technology Co., Ltd.
- Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD
- JSC Pharmstandard
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Umifenovir Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Umifenovir Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Umifenovir Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Umifenovir Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Umifenovir Market Dynamics
- 2.1 Umifenovir Industry Trends
- 2.2 Umifenovir Industry Drivers
- 2.3 Umifenovir Industry Opportunities and Challenges
- 2.4 Umifenovir Industry Restraints
3 Umifenovir Market by Manufacturers
- 3.1 Global Umifenovir Revenue by Manufacturers (2021-2026)
- 3.2 Global Umifenovir Sales by Manufacturers (2021-2026)
- 3.3 Global Umifenovir Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Umifenovir Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Umifenovir Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Umifenovir Manufacturers, Product Type & Application
- 3.7 Global Umifenovir Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Umifenovir Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Umifenovir Players Market Share by Revenue in 2025
- 3.8.3 2025 Umifenovir Tier 1, Tier 2, and Tier 3
4 Umifenovir Market by Type
- 4.1 Umifenovir Type Introduction
- 4.1.1 Tablet
- 4.1.2 Capsule
- 4.1.3 Others
- 4.2 Global Umifenovir Sales by Type
- 4.2.1 Global Umifenovir Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Umifenovir Sales by Type (2021-2032)
- 4.2.3 Global Umifenovir Sales Market Share by Type (2021-2032)
- 4.3 Global Umifenovir Revenue by Type
- 4.3.1 Global Umifenovir Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Umifenovir Revenue by Type (2021-2032)
- 4.3.3 Global Umifenovir Revenue Market Share by Type (2021-2032)
5 Umifenovir Market by Application
- 5.1 Umifenovir Application Introduction
- 5.1.1 Drug Store
- 5.1.2 Hospital
- 5.1.3 Clinics
- 5.1.4 Others
- 5.2 Global Umifenovir Sales by Application
- 5.2.1 Global Umifenovir Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Umifenovir Sales by Application (2021-2032)
- 5.2.3 Global Umifenovir Sales Market Share by Application (2021-2032)
- 5.3 Global Umifenovir Revenue by Application
- 5.3.1 Global Umifenovir Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Umifenovir Revenue by Application (2021-2032)
- 5.3.3 Global Umifenovir Revenue Market Share by Application (2021-2032)
6 Global Umifenovir Sales by Region
- 6.1 Global Umifenovir Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Umifenovir Sales by Region (2021-2032)
- 6.2.1 Global Umifenovir Sales by Region (2021-2026)
- 6.2.2 Global Umifenovir Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Umifenovir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Umifenovir Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Umifenovir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Umifenovir Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Umifenovir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Umifenovir Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Umifenovir Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Umifenovir Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Umifenovir Revenue by Region
- 7.1 Global Umifenovir Revenue by Region
- 7.1.1 Global Umifenovir Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Umifenovir Revenue by Region (2021-2026)
- 7.1.3 Global Umifenovir Revenue by Region (2027-2032)
- 7.1.4 Global Umifenovir Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Umifenovir Revenue (2021-2032)
- 7.2.2 North America Umifenovir Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Umifenovir Revenue (2021-2032)
- 7.3.2 Europe Umifenovir Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Umifenovir Revenue (2021-2032)
- 7.4.2 Asia-Pacific Umifenovir Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Umifenovir Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Umifenovir Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Yichang Tianren Pharmaceutical Co.,Ltd
- 8.1.1 Yichang Tianren Pharmaceutical Co.,Ltd Company Information
- 8.1.2 Yichang Tianren Pharmaceutical Co.,Ltd Business Overview
- 8.1.3 Yichang Tianren Pharmaceutical Co.,Ltd Umifenovir Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Yichang Tianren Pharmaceutical Co.,Ltd Umifenovir Product Portfolio
- 8.1.5 Yichang Tianren Pharmaceutical Co.,Ltd Recent Developments
- 8.2 Shenyang Coupling Biomedical Technology Co., Ltd.
- 8.2.1 Shenyang Coupling Biomedical Technology Co., Ltd. Company Information
- 8.2.2 Shenyang Coupling Biomedical Technology Co., Ltd. Business Overview
- 8.2.3 Shenyang Coupling Biomedical Technology Co., Ltd. Umifenovir Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shenyang Coupling Biomedical Technology Co., Ltd. Umifenovir Product Portfolio
- 8.2.5 Shenyang Coupling Biomedical Technology Co., Ltd. Recent Developments
- 8.3 Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD
- 8.3.1 Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD Company Information
- 8.3.2 Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD Business Overview
- 8.3.3 Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD Umifenovir Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD Umifenovir Product Portfolio
- 8.3.5 Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD Recent Developments
- 8.4 JSC Pharmstandard
- 8.4.1 JSC Pharmstandard Company Information
- 8.4.2 JSC Pharmstandard Business Overview
- 8.4.3 JSC Pharmstandard Umifenovir Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 JSC Pharmstandard Umifenovir Product Portfolio
- 8.4.5 JSC Pharmstandard Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Umifenovir Value Chain Analysis
- 9.1.1 Umifenovir Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Umifenovir Production Mode & Process
- 9.2 Umifenovir Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Umifenovir Distributors
- 9.2.3 Umifenovir Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst